Purchases and Sales Made in Q4 2022 in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA) during Q4 2022. The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Candriam S.C.A.
|
SELL
|
- |
-50K- 35.39% |
$1.66M - $3.13M
|
91.3K
$1.11M
|
|
|
Feb 14, 2023
Q4 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-62K- 19.08% |
$2.06M - $3.89M
|
263K
$3.2M
|
|
|
Feb 06, 2023
Q4 2022
|
Banque Pictet & Cie Sa
|
SELL
|
- |
-83.4K- 78.32% |
$2.77M - $5.23M
|
23.1K
$281K
|
|
|
Feb 09, 2023
Q4 2022
|
Chevy Chase Trust Holdings, Inc.
Bethesda, MD |
SELL
|
- |
-165K- 14.54% |
$5.49M - $10.4M
|
972K
$11.8M
|
|
|
Jan 24, 2023
Q4 2022
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-236K- 2.45% |
$7.85M - $14.8M
|
9.42M
$115M
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-280K- 84.83% |
$9.31M - $17.6M
|
50.1K
$610K
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-355K- 36.13% |
$11.8M - $22.2M
|
627K
$7.64M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-355K- 36.13% |
$11.8M - $22.2M
|
627K
$7.64M
|
|
|
Feb 14, 2023
Q4 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-361K- 36.12% |
$12M - $22.6M
|
638K
$7.77M
|